Arno Therapeutics Advances Phase I/II Trial Evaluating Onapristone in Prostate Cancer to Phase II
Mar 21, 2016 11:30 am UTC| Business
- Phase II to include study of onapristone in combination with abiraterone - FLEMINGTON, N.J., March 21, 2016 -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the...
OpGen Announces New Members to its Clinical Advisory Board
Mar 21, 2016 11:30 am UTC| Business
GAITHERSBURG, Md., March 21, 2016 -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announced that four new members have joined its...
Mar 21, 2016 11:24 am UTC| Business
Dublin, March 21, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/vktsfz/carboxymethyl) has announced the addition of the "Carboxymethyl Cellulose - Global Strategic Business...
Mar 21, 2016 11:18 am UTC| Business
Dublin, March 21, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/fdcktt/industrial) has announced the addition of the "Industrial Fasteners - Global Strategic Business Report" ...
Sonoco Issues 2015 Annual Report to Shareholders
Mar 21, 2016 11:15 am UTC| Business
HARTSVILLE, S.C., March 21, 2016 -- Sonoco (NYSE:SON), one of the largest diversified global packaging companies, today announced that its 2015 Annual Report to Shareholders is now available on the Company's website at...
Mar 21, 2016 11:05 am UTC| Business
PRINCETON, N.J., March 21, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that data from a dose-escalation study of ADXS-HER2 in canine...
Mar 21, 2016 11:05 am UTC| Business
SALT LAKE CITY, March 21, 2016 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, and Access Health®, an educational program focused on health and wellness, today...